Disclaimer This document contains data provided to WHO by member states. Note that some member states only provide aggregate data to WHO, and for these,

Disclaimer This document contains data provided to WHO by member states. Note that some member states only provide aggregate data to WHO, and for these, we are unable to generate a country profile. Some member states report all cases at one time point for the entire year, and thus epidemiologic curves generated are not accurate and a reporting artifact. For some countries, cases are reported by age category, not by exact age in months and/or years. Thus, age distribution/incidence is approximate. Cases classified as pending by countries are classified at WHO as clinically compatible at this time, and thus numbers might different between data shown here and provided by the member state or WHO country/regional offices. *UN population data is used as the denominator for calculating incidence. Notes: Based on data received This is surveillance data, hence for the last month, the data may be incomplete.

Rubella cases: Afghanistan
5 10 15 Clinical Epi Lab Month of onset Number of cases Notes: Based on data received This is surveillance data, hence for the last month, the data may be incomplete. 5 10 15 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Afghanistan age distribution, vaccination status, and incidence, to Incidence rate per 1,000,000 8.9 3.8 1.4 1.1 0.3 0.2 Year Confirmed Cases 2015 54 2016 42 2017 53 2018 37 2019 6

Rubella cases: Algeria
10 20 Clinical Epi Lab Month of onset Number of cases Cov: 45% National SIA Sub-national SIA 2 4 6 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Algeria age distribution, vaccination status, and incidence, to 0.5 1 1.5 Incidence rate per 1,000,000 1.1 1.4 0.3 Year Confirmed Cases 2015 2 2016 11 2017 22 2018 32

Rubella cases: Angola 5 Month of onset Number of cases 5 10 15
5 Clinical Epi Lab Month of onset Number of cases Cov: 93% National SIA Sub-national SIA 5 10 15 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Angola age distribution, vaccination status, and incidence, to 1 2 3 Incidence rate per 1,000,000 3.2 2.8 1.2 0.8 0.2 0.3 Year Confirmed Cases 2015 228 2016 12 2017 19 2018 33 2019 2

Rubella cases: Bangladesh
20 40 60 Clinical Epi Lab Month of onset Number of cases SIA (9 M-<5 Y) Cov: 99.8% SIA (6 M-<15 Y) Cov: 107% National SIA Sub-national SIA 20 40 60 80 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Bangladesh age distribution, vaccination status, and incidence, to 5 10 15 Incidence rate per 1,000,000 19.4 5.8 4.3 2.1 1.4 0.3 Year Confirmed Cases 2015 189 2016 165 2017 299 2018 308 2019 5

Rubella cases: Belarus
1 2 Clinical Epi Lab Month of onset Number of cases 1 2 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Belarus age distribution, vaccination status, and incidence, to 0.5 Incidence rate per 1,000,000 0.9 Year Confirmed Cases 2015 1 2016 2017 2018 2 2019

Rubella cases: Benin 5 Month of onset Number of cases 2 4 6
5 Clinical Epi Lab Month of onset Number of cases 2 4 6 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Benin age distribution, vaccination status, and incidence, to 1 3 Incidence rate per 1,000,000 1.3 1.5 Year Confirmed Cases 2015 34 2016 3 2017 2018 10 2019

Rubella cases: Bhutan 4 3 Number of cases 2 1 Month of onset 2 15
1 2 3 4 Clinical Epi Lab Month of onset Number of cases 1 2 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Bhutan age distribution, vaccination status, and incidence, to 5 10 15 Incidence rate per 1,000,000 14 Year Confirmed Cases 2015 1 2016 2017 8 2018 2019

Rubella cases: Bosnia and Herzegovina
1 2 Clinical Epi Lab Month of onset Number of cases 1 2 <1 year 1-4 years 5-9 years 10-14 years 15-19 years 20-29 years 30+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Bosnia and Herzegovina age distribution, vaccination status, and incidence, to 10 20 30 Incidence rate per 1,000,000 0.5 Year Confirmed Cases 2015 8 2016 2017 1 2018 3 2019

Rubella cases: Botswana
1 2 3 Clinical Epi Lab Month of onset Number of cases 1 2 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Botswana age distribution, vaccination status, and incidence, to 5 10 15 20 Incidence rate per 1,000,000 18.6 4.7 4.2 Year Confirmed Cases 2015 5 2016 13 2017 3 2018

Rubella cases: Bulgaria
1 2 Clinical Epi Lab Month of onset Number of cases 1 2 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Bulgaria age distribution, vaccination status, and incidence, to 3 4 Incidence rate per 1,000,000 3.7 Year Confirmed Cases 2015 5 2016 3 2017 2018 1 2019

Rubella cases: Burkina Faso
1 2 Clinical Epi Lab Month of onset Number of cases 1 2 3 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Burkina Faso age distribution, vaccination status, and incidence, to 0.5 Incidence rate per 1,000,000 0.7 0.3 Year Confirmed Cases 2015 4 2016 1 2017 2018 3 2019

Rubella cases: Burundi
1 2 3 4 Clinical Epi Lab Month of onset Number of cases 1 2 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Burundi age distribution, vaccination status, and incidence, to Incidence rate per 1,000,000 2.2 0.6 0.8 Year Confirmed Cases 2015 61 2016 21 2017 5 2018 6 2019

Rubella cases: Cambodia
1 2 3 4 Clinical Epi Lab Month of onset Number of cases 1 2 3 4 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Cambodia age distribution, vaccination status, and incidence, to 0.5 Incidence rate per 1,000,000 0.7 0.6 0.9 Year Confirmed Cases 2014 31 2015 18 2016 4 2017 7 2018 3 2019 2

Rubella cases: Cameroon
5 Clinical Epi Lab Month of onset Number of cases 1 2 3 4 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Cameroon age distribution, vaccination status, and incidence, to Incidence rate per 1,000,000 3.8 0.7 0.6 Year Confirmed Cases 2015 277 2016 15 2017 12 2018 7 2019

Rubella cases: Central African Republic
5 10 Clinical Epi Lab Month of onset Number of cases 1 2 3 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Central African Republic age distribution, vaccination status, and incidence, to 4 Incidence rate per 1,000,000 1.6 3.4 Year Confirmed Cases 2015 346 2016 35 2017 19 2018 3 2019

Rubella cases: Chad 10 20 Month of onset Number of cases 5 10 15 20 25
10 20 Clinical Epi Lab Month of onset Number of cases 5 10 15 20 25 30 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Chad age distribution, vaccination status, and incidence, to Incidence rate per 1,000,000 1.8 7.3 10.9 1.6 0.7 Year Confirmed Cases 2015 31 2016 24 2017 2018 49 2019

Rubella cases: China 800 Number of cases 600 400 200 Month of onset
200 400 600 800 Clinical Epi Lab Month of onset Number of cases Year Confirmed Cases 2014 11887 2015 8247 2016 4477 2017 1601 2018 3158 2019 683

Rubella cases: Congo 20 Number of cases 10 Month of onset 100
10 20 Clinical Epi Lab Month of onset Number of cases SIA (9 M-14 Y) National SIA Sub-national SIA 20 40 60 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Congo age distribution, vaccination status, and incidence, to 80 100 Incidence rate per 1,000,000 25.1 70 94.5 10.8 4.7 1.1 Year Confirmed Cases 2015 4 2016 2017 12 2018 120 2019

Rubella cases: Cote d'Ivoire
20 40 60 80 100 120 Clinical Epi Lab Month of onset Number of cases SIA (9 M-14 Y) Cov: 98.3% National SIA Sub-national SIA 20 40 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Cote d'Ivoire age distribution, vaccination status, and incidence, to 5 10 15 25 Incidence rate per 1,000,000 23 14.2 9.2 4.3 2.8 1.8 0.5 Year Confirmed Cases 2015 50 2016 192 2017 329 2018 177 2019 13

Rubella cases: Czech Republic
1 2 Clinical Epi Lab Month of onset Number of cases 1 2 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Czech Republic age distribution, vaccination status, and incidence, to Incidence rate per 1,000,000 0.4 0.2 Year Confirmed Cases 2015 1 2016 2017 2 2018 2019

Rubella cases: Democratic Republic of the Congo
20 40 60 80 100 120 Clinical Epi Lab Month of onset Number of cases 20 40 60 80 100 120 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Democratic Republic of the Congo age distribution, vaccination status, and incidence, to 5 10 Incidence rate per 1,000,000 4.7 8.7 9.1 1.8 0.3 0.2 Year Confirmed Cases 2015 485 2016 218 2017 684 2018 285 2019

Rubella cases: Egypt Number of cases 5 Month of onset 6
5 Clinical Epi Lab Month of onset Number of cases 2 4 6 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Egypt age distribution, vaccination status, and incidence, to 0.5 Incidence rate per 1,000,000 0.4 0.6 Year Confirmed Cases 2015 20 2016 2017 33 2018 7 2019

Rubella cases: Equatorial Guinea
1 2 3 Clinical Epi Lab Month of onset Number of cases 1 2 3 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Equatorial Guinea age distribution, vaccination status, and incidence, to 10 20 30 40 Incidence rate per 1,000,000 36.5 9.9 18.2 Year Confirmed Cases 2015 13 2016 2 2017 4 2018 5 2019

Rubella cases: Eritrea
5 Clinical Epi Lab Month of onset Number of cases SIA (9 M-14 Y) National SIA Sub-national SIA 1 2 3 4 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Eritrea age distribution, vaccination status, and incidence, to Incidence rate per 1,000,000 4.6 2.6 Year Confirmed Cases 2015 10 2016 43 2017 2 2018 5

Rubella cases: Ethiopia
50 100 150 Clinical Epi Lab Month of onset Number of cases 100 200 300 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Ethiopia age distribution, vaccination status, and incidence, to 5 10 15 20 25 Incidence rate per 1,000,000 2.3 19.9 22 4.1 1.1 0.4 Year Confirmed Cases 2015 323 2016 181 2017 310 2018 682

Rubella cases: Gabon 1 2 3 Month of onset Number of cases 2 4 6
1 2 3 Clinical Epi Lab Month of onset Number of cases 2 4 6 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Gabon age distribution, vaccination status, and incidence, to 5 10 15 20 25 Incidence rate per 1,000,000 21.1 Year Confirmed Cases 2015 59 2016 3 2017 2018 4 2019

Rubella cases: Gambia 2 Number of cases 1 Month of onset 2
1 2 Clinical Epi Lab Month of onset Number of cases 1 2 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Gambia age distribution, vaccination status, and incidence, to 3 Incidence rate per 1,000,000 3.3 Year Confirmed Cases 2015 1 2016 2017 2018 2019

Rubella cases: Georgia
1 2 3 4 Clinical Epi Lab Month of onset Number of cases 1 2 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Georgia age distribution, vaccination status, and incidence, to 5 10 15 20 Incidence rate per 1,000,000 18.8 1.8 0.5 Year Confirmed Cases 2015 100 2016 12 2017 5 2018 2019 3

Rubella cases: Germany
5 10 15 Clinical Epi Lab Month of onset Number of cases 5 10 15 20 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Germany age distribution, vaccination status, and incidence, to Incidence rate per 1,000,000 8.8 6.7 1.8 0.6 0.3 0.2 Year Confirmed Cases 2015 91 2016 96 2017 74 2018 57

Rubella cases: Ghana Number of cases 5 Month of onset 20 6
5 Clinical Epi Lab Month of onset Number of cases Cov: 94.6% National SIA Sub-national SIA 5 10 15 20 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Ghana age distribution, vaccination status, and incidence, to 2 4 6 Incidence rate per 1,000,000 Year Confirmed Cases 2015 12 2016 10 2017 7 2018 20 2019 1

Rubella cases: Guinea 80 Number of cases 60 40 20 Month of onset 8
20 40 60 80 Clinical Epi Lab Month of onset Number of cases 2 4 6 8 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Guinea age distribution, vaccination status, and incidence, to 1 3 Incidence rate per 1,000,000 3.1 1.3 Year Confirmed Cases 2015 2016 36 2017 167 2018 17 2019

Rubella cases: India 1000 800 Number of cases 600 400 200
200 400 600 800 1000 Clinical Epi Lab Month of onset Number of cases SIA (9 M-15 Y) Cov: 96.7% Cov: 100.9% Cov: 106.9% Cov: 97.1% Cov: 101.6% Cov: 101.9% Cov: 84.8% Cov: 101.4% Cov: 98.3% Cov: 101.1% Cov: 96.9% Cov: 93.98% Cov: 100% Cov: 99% Cov: 95.98% Cov: 96% Cov: 95.1% Cov: 93.5% Cov: 99.6% Cov: 97.8% National SIA Sub-national SIA 200 400 600 800 1000 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases India age distribution, vaccination status, and incidence, to 2 4 6 Incidence rate per 1,000,000 5.8 4.9 6.3 3.2 0.7 0.3 0.1 Year Confirmed Cases 2015 3265 2016 9084 2017 3049 2018 2236 2019 40

Rubella cases: Indonesia
200 400 600 Clinical Epi Lab Month of onset Number of cases SIA (9 M-15 Y) Cov: 101% Cov: 73% National SIA Sub-national SIA 100 200 300 400 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Indonesia age distribution, vaccination status, and incidence, to 5 10 15 20 Incidence rate per 1,000,000 16.7 7.6 16.8 14.8 1.7 0.3 Year Confirmed Cases 2015 1379 2016 1170 2017 4363 2018 1461 2019 47

Rubella cases: Ireland
1 2 Clinical Epi Lab Month of onset Number of cases 1 2 3 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Ireland age distribution, vaccination status, and incidence, to 4 6 Incidence rate per 1,000,000 3.5 5.6 Year Confirmed Cases 2015 9 2016 1 2017 2018 4 2019

Rubella cases: Israel 2 Number of cases 1 Month of onset 2
1 2 Clinical Epi Lab Month of onset Number of cases 1 2 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Israel age distribution, vaccination status, and incidence, to 0.5 Incidence rate per 1,000,000 0.8 0.6 Year Confirmed Cases 2015 1 2016 2017 2018 2 2019

Rubella cases: Italy 15 Number of cases 10 5 Month of onset 8
5 10 15 Clinical Epi Lab Month of onset Number of cases 2 4 6 8 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Italy age distribution, vaccination status, and incidence, to 1 3 Incidence rate per 1,000,000 2.9 0.4 0.5 0.3 0.2 Year Confirmed Cases 2015 37 2016 30 2017 68 2018 21 2019 2

Rubella cases: Japan 100 200 300 Month of onset Number of cases 50 100
100 200 300 Clinical Epi Lab Month of onset Number of cases 50 100 150 200 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Japan age distribution, vaccination status, and incidence, to 2 4 6 8 Incidence rate per 1,000,000 1.9 0.5 0.4 0.7 4.5 6.7 2.2 Year Confirmed Cases 2014 2015 2 2016 3 2017 5 2018 68 2019 320

Rubella cases: Kazakhstan
1 2 Clinical Epi Lab Month of onset Number of cases 1 2 <1 year 1-4 years 5-9 years 10-14 years 15-19 years 20-29 years 30+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Kazakhstan age distribution, vaccination status, and incidence, to Incidence rate per 1,000,000 0.4 0.2 Year Confirmed Cases 2015 2 2016 4 2017 2018 1 2019

Rubella cases: Kenya Number of cases 5 Month of onset 10
5 Clinical Epi Lab Month of onset Number of cases 5 10 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Kenya age distribution, vaccination status, and incidence, to 0.5 1 1.5 Incidence rate per 1,000,000 1.3 1.6 0.8 0.2 0.1 Year Confirmed Cases 2015 421 2016 257 2017 13 2018 23 2019

Rubella cases: Kuwait 1 2 Month of onset Number of cases 1 2 3
1 2 Clinical Epi Lab Month of onset Number of cases 1 2 3 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Kuwait age distribution, vaccination status, and incidence, to 4 6 8 Incidence rate per 1,000,000 7.3 0.7 Year Confirmed Cases 2015 2016 3 2017 1 2018

Rubella cases: Kyrgyzstan
5 Clinical Epi Lab Month of onset Number of cases 1 2 3 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Kyrgyzstan age distribution, vaccination status, and incidence, to Incidence rate per 1,000,000 3.2 0.7 0.6 Year Confirmed Cases 2015 100 2016 2 2017 4 2018 8 2019

Rubella cases: Lao People's Democratic Republic
5 Clinical Epi Lab Month of onset Number of cases 1 2 3 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Lao People's Democratic Republic age distribution, vaccination status, and incidence, to 5 10 Incidence rate per 1,000,000 11.7 1.5 Year Confirmed Cases 2014 15 2015 22 2016 34 2017 12 2018 2019 1

Rubella cases: Latvia 2 Number of cases 1 Month of onset 2
1 2 Clinical Epi Lab Month of onset Number of cases 1 2 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Latvia age distribution, vaccination status, and incidence, to 5 10 Incidence rate per 1,000,000 10.9 2.5 Year Confirmed Cases 2015 2016 2017 2018 3 2019

Rubella cases: Lebanon
5 Clinical Epi Lab Month of onset Number of cases SIA (1-15 Y) Cov: 83% National SIA Sub-national SIA 2 4 6 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Lebanon age distribution, vaccination status, and incidence, to 5 10 15 20 25 Incidence rate per 1,000,000 23.6 10.6 2.1 0.5 Year Confirmed Cases 2015 9 2016 10 2017 2018 13

Rubella cases: Liberia
10 20 30 40 Clinical Epi Lab Month of onset Number of cases 10 20 30 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Liberia age distribution, vaccination status, and incidence, to 40 Incidence rate per 1,000,000 36.1 40.8 19.4 5.8 2.2 2.4 Year Confirmed Cases 2015 2016 2017 2018 59 2019 10

Rubella cases: Libya 5 Number of cases Month of onset 6
5 Clinical Epi Lab Month of onset Number of cases SIA (3-6 Y) Cov: 101% National SIA Sub-national SIA 2 4 6 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Libya age distribution, vaccination status, and incidence, to 5 10 15 Incidence rate per 1,000,000 15.8 11.5 6.2 1.7 1 Year Confirmed Cases 2015 2016 2017 2 2018 14

Rubella cases: Lithuania
1 2 Clinical Epi Lab Month of onset Number of cases 1 2 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Lithuania age distribution, vaccination status, and incidence, to Incidence rate per 1,000,000 1.9 Year Confirmed Cases 2015 2016 2017 2018 1 2019

Rubella cases: Madagascar
10 20 30 Clinical Epi Lab Month of onset Number of cases 5 10 15 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Madagascar age distribution, vaccination status, and incidence, to 2 4 Incidence rate per 1,000,000 2.5 3.4 4.5 2.3 1 0.2 Year Confirmed Cases 2015 89 2016 204 2017 155 2018 46 2019

Rubella cases: Malawi 5 Number of cases Month of onset 4
5 Clinical Epi Lab Month of onset Number of cases Cov: 102% National SIA Sub-national SIA 1 2 3 4 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Malawi age distribution, vaccination status, and incidence, to Incidence rate per 1,000,000 3.2 1.3 0.4 Year Confirmed Cases 2015 99 2016 33 2017 25 2018 6

Rubella cases: Malaysia
10 20 Clinical Epi Lab Month of onset Number of cases 20 40 60 80 100 120 140 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Malaysia age distribution, vaccination status, and incidence, to 50 150 200 250 Incidence rate per 1,000,000 235.3 11.7 2.1 0.4 0.7 1.4 0.3 Year Confirmed Cases 2014 230 2015 34 2016 70 2017 115 2018 180 2019 2

Rubella cases: Mali 60 Number of cases 40 20 Month of onset 60
20 40 60 Clinical Epi Lab Month of onset Number of cases 20 40 60 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Mali age distribution, vaccination status, and incidence, to 5 10 15 Incidence rate per 1,000,000 7.2 13.2 18.6 6.1 0.3 0.9 Year Confirmed Cases 2015 171 2016 65 2017 18 2018 112 2019

Rubella cases: Mauritania
1 2 Clinical Epi Lab Month of onset Number of cases National SIA Sub-national SIA 1 2 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Mauritania age distribution, vaccination status, and incidence, to Incidence rate per 1,000,000 1.8 Year Confirmed Cases 2015 9 2016 2017 2018 1 2019

Rubella cases: Mexico 2 Number of cases 1 Month of onset 2
1 2 Clinical Epi Lab Month of onset Number of cases 1 2 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Mexico age distribution, vaccination status, and incidence, to Incidence rate per 1,000,000 0.1 Year Confirmed Cases 2008 2009 2010 2012 2013 2014 2015 2016 2017 2018 2 2019

Rubella cases: Mongolia
5 Clinical Epi Lab Month of onset Number of cases 1 2 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Mongolia age distribution, vaccination status, and incidence, to 5 10 15 Incidence rate per 1,000,000 14.8 Year Confirmed Cases 2014 2015 25 2016 19 2017 11 2018 1 2019

Rubella cases: Morocco
1 2 3 4 Clinical Epi Lab Month of onset Number of cases 2 4 6 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Morocco age distribution, vaccination status, and incidence, to Incidence rate per 1,000,000 5.9 1.1 0.3 0.2 Year Confirmed Cases 2015 4 2016 2017 6 2018 9 2019

Rubella cases: Mozambique
20 40 Clinical Epi Lab Month of onset Number of cases SIA (9 M-14 Y) Cov: 102% National SIA Sub-national SIA 20 40 60 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Mozambique age distribution, vaccination status, and incidence, to 5 10 15 Incidence rate per 1,000,000 14.7 13.2 5.7 1.4 0.2 Year Confirmed Cases 2015 363 2016 81 2017 48 2018 106 2019

Rubella cases: Myanmar
1 2 3 4 Clinical Epi Lab Month of onset Number of cases 2 4 6 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Myanmar age distribution, vaccination status, and incidence, to 0.5 1 Incidence rate per 1,000,000 1.1 0.8 0.2 0.9 0.1 Year Confirmed Cases 2015 34 2016 10 2017 6 2018 13 2019 1

Rubella cases: Namibia
5 10 Clinical Epi Lab Month of onset Number of cases 2 4 6 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Namibia age distribution, vaccination status, and incidence, to 5 10 15 Incidence rate per 1,000,000 13.7 Year Confirmed Cases 2015 414 2016 37 2017 17 2018 5 2019

Rubella cases: Nepal 10 Number of cases 5 Month of onset 20 30
5 10 Clinical Epi Lab Month of onset Number of cases 5 10 15 20 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Nepal age distribution, vaccination status, and incidence, to 30 Incidence rate per 1,000,000 28.5 5.8 0.3 0.9 Year Confirmed Cases 2015 8 2016 22 2017 2018 34 2019 1

Rubella cases: Niger 15 Number of cases 10 5 Month of onset 10 3
5 10 15 Clinical Epi Lab Month of onset Number of cases 5 10 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Niger age distribution, vaccination status, and incidence, to 1 2 3 Incidence rate per 1,000,000 2.1 1.2 2.7 1.1 Year Confirmed Cases 2015 24 2016 2017 10 2018 19 2019

Rubella cases: Nigeria
20 40 60 80 100 120 Clinical Epi Lab Month of onset Number of cases 50 100 150 200 250 300 350 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Nigeria age distribution, vaccination status, and incidence, to 5 10 Incidence rate per 1,000,000 5.1 11.4 7 1.9 0.6 0.4 0.2 Year Confirmed Cases 2015 450 2016 465 2017 290 2018 558 2019 68

Rubella cases: Pakistan
50 100 150 Clinical Epi Lab Month of onset Number of cases 50 100 150 200 250 300 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Pakistan age distribution, vaccination status, and incidence, to 5 10 15 20 25 Incidence rate per 1,000,000 24.8 13.9 3.3 1.3 0.2 0.6 Year Confirmed Cases 2015 221 2016 616 2017 388 2018 558 2019 12

Rubella cases: Papua New Guinea
1 2 Clinical Epi Lab Month of onset Number of cases National SIA Sub-national SIA 1 2 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Papua New Guinea age distribution, vaccination status, and incidence, to 4 Incidence rate per 1,000,000 4.9 Year Confirmed Cases 2014 2015 4 2016 1 2017 2018

Rubella cases: Philippines
20 40 60 80 100 Clinical Epi Lab Month of onset Number of cases 10 20 30 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Philippines age distribution, vaccination status, and incidence, to 5 Incidence rate per 1,000,000 11.8 2.5 0.7 0.5 1.5 0.2 Year Confirmed Cases 2014 343 2015 154 2016 165 2017 474 2018 129

Rubella cases: Poland 60 Number of cases 40 20 Month of onset 150
20 40 60 Clinical Epi Lab Month of onset Number of cases 50 100 150 <1 year 1-4 years 5-9 years 10-14 years 15-19 years 20-29 years 30+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Poland age distribution, vaccination status, and incidence, to Incidence rate per 1,000,000 142.9 82 75.1 21 2.9 4.3 1.7 Year Confirmed Cases 2015 2029 2016 1105 2017 476 2018 450 2019 47

Rubella cases: Portugal
1 2 3 Clinical Epi Lab Month of onset Number of cases 1 2 3 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Portugal age distribution, vaccination status, and incidence, to 4 Incidence rate per 1,000,000 2.8 4.1 0.9 Year Confirmed Cases 2015 7 2016 8 2017 4 2018 5 2019 1

Rubella cases: Romania
1 2 3 Clinical Epi Lab Month of onset Number of cases 2 4 6 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Romania age distribution, vaccination status, and incidence, to 5 10 Incidence rate per 1,000,000 11.3 6.7 0.2 Year Confirmed Cases 2015 8 2016 13 2017 9 2018 2019

Rubella cases: Russian Federation
1 2 3 Clinical Epi Lab Month of onset Number of cases 1 2 3 4 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Russian Federation age distribution, vaccination status, and incidence, to Incidence rate per 1,000,000 0.1 0.2 Year Confirmed Cases 2015 13 2016 37 2017 7 2018 6 2019 2

Rubella cases: Rwanda 5 Number of cases Month of onset 4
5 Clinical Epi Lab Month of onset Number of cases Cov: 98% Cov: 102% National SIA Sub-national SIA 1 2 3 4 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Rwanda age distribution, vaccination status, and incidence, to Incidence rate per 1,000,000 2.2 1.2 0.4 Year Confirmed Cases 2015 1 2016 14 2017 2018 5 2019

Rubella cases: Saudi Arabia
5 10 Clinical Epi Lab Month of onset Number of cases 5 10 15 20 25 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Saudi Arabia age distribution, vaccination status, and incidence, to Incidence rate per 1,000,000 9.8 8.6 1.9 0.7 0.2 0.5 Year Confirmed Cases 2015 4 2016 21 2017 38 2018 45

Rubella cases: Senegal
1 2 3 Clinical Epi Lab Month of onset Number of cases National SIA Sub-national SIA 1 2 3 4 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Senegal age distribution, vaccination status, and incidence, to Incidence rate per 1,000,000 1.8 1.5 1.4 0.5 Year Confirmed Cases 2015 15 2016 12 2017 7 2018 8 2019 2

Rubella cases: Sierra Leone
100 200 Clinical Epi Lab Month of onset Number of cases 1 2 3 4 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Sierra Leone age distribution, vaccination status, and incidence, to Incidence rate per 1,000,000 4.8 1.3 3.3 Year Confirmed Cases 2015 9 2016 97 2017 347 2018 6

Rubella cases: Singapore
5 Clinical Epi Lab Month of onset Number of cases 2 4 6 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Singapore age distribution, vaccination status, and incidence, to Incidence rate per 1,000,000 3.1 5.4 5 1.4 Year Confirmed Cases 2014 2015 1 2016 2017 3 2018 15 2019

Rubella cases: Slovakia
1 2 Clinical Epi Lab Month of onset Number of cases 1 2 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Slovakia age distribution, vaccination status, and incidence, to Incidence rate per 1,000,000 0.4 Year Confirmed Cases 2015 2016 2017 2018 1 2019

Rubella cases: South Africa
100 200 300 400 500 Clinical Epi Lab Month of onset Number of cases 50 100 150 200 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases South Africa age distribution, vaccination status, and incidence, to 10 20 30 40 Incidence rate per 1,000,000 9.3 41 31 5.2 1.1 0.4 0.1 Year Confirmed Cases 2015 81 2016 642 2017 1595 2018 448 2019 20

Rubella cases: South Sudan
10 20 Clinical Epi Lab Month of onset Number of cases 5 10 15 20 25 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases South Sudan age distribution, vaccination status, and incidence, to Incidence rate per 1,000,000 4.8 13 7.6 3.3 Year Confirmed Cases 2015 47 2016 31 2017 71 2018 44 2019 9

Rubella cases: Spain 10 Number of cases 5 Month of onset 10
5 10 Clinical Epi Lab Month of onset Number of cases 5 10 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Spain age distribution, vaccination status, and incidence, to 1 2 Incidence rate per 1,000,000 2.4 1.1 0.7 0.1 Year Confirmed Cases 2015 4 2016 2 2017 1 2018 13 2019 6

Rubella cases: Sudan 80 Number of cases 60 40 20 Month of onset 150 25
20 40 60 80 Clinical Epi Lab Month of onset Number of cases 50 100 150 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Sudan age distribution, vaccination status, and incidence, to 5 10 15 20 25 Incidence rate per 1,000,000 12.8 19.8 23.9 7.5 3.6 0.6 Year Confirmed Cases 2015 1052 2016 996 2017 259 2018 349

Rubella cases: Switzerland
1 2 Clinical Epi Lab Month of onset Number of cases 1 2 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Switzerland age distribution, vaccination status, and incidence, to 0.5 Incidence rate per 1,000,000 1.1 0.6 Year Confirmed Cases 2015 3 2016 2017 1 2018 2 2019

Rubella cases: Syrian Arab Republic
1 2 3 Clinical Epi Lab Month of onset Number of cases 2 4 6 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Syrian Arab Republic age distribution, vaccination status, and incidence, to 1 3 Incidence rate per 1,000,000 3.4 Year Confirmed Cases 2015 2016 1 2017 2018 6

Rubella cases: Thailand
5 10 15 Clinical Epi Lab Month of onset Number of cases 5 10 15 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Thailand age distribution, vaccination status, and incidence, to 20 Incidence rate per 1,000,000 19.8 3.6 0.7 1 0.9 0.1 Year Confirmed Cases 2015 36 2016 7 2017 24 2018 52 2019 9

Rubella cases: Timor-Leste
1 2 3 Clinical Epi Lab Month of onset Number of cases 1 2 3 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Timor-Leste age distribution, vaccination status, and incidence, to 20 40 Incidence rate per 1,000,000 47.5 12.4 6.7 Year Confirmed Cases 2015 5 2016 9 2017 2018 6 2019

Rubella cases: Togo 20 Number of cases 10 Month of onset 20
10 20 Clinical Epi Lab Month of onset Number of cases SIA (9 M-14 Y) Cov: 98% National SIA Sub-national SIA 5 10 15 20 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Togo age distribution, vaccination status, and incidence, to Incidence rate per 1,000,000 4.1 14.2 18.4 3.4 0.8 Year Confirmed Cases 2015 57 2016 274 2017 37 2018 40 2019

Rubella cases: Tunisia
5 Clinical Epi Lab Month of onset Number of cases 5 10 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Tunisia age distribution, vaccination status, and incidence, to 15 Incidence rate per 1,000,000 12.8 7 3.8 0.4 Year Confirmed Cases 2015 25 2016 19 2017 11 2018 21 2019 1

Rubella cases: Turkey 5 Number of cases Month of onset 6
5 Clinical Epi Lab Month of onset Number of cases SIA (refugees) Cov: 7.227% Cov: 7.183% National SIA Sub-national SIA 2 4 6 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Turkey age distribution, vaccination status, and incidence, to 0.5 1 1.5 Incidence rate per 1,000,000 1.6 1.1 0.6 0.2 0.1 Year Confirmed Cases 2015 2016 2017 2 2018 16 2019

Rubella cases: Uganda 80 60 Number of cases 40 20 Month of onset 40
20 40 60 80 Clinical Epi Lab Month of onset Number of cases 50 100 150 200 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Uganda age distribution, vaccination status, and incidence, to 10 20 30 40 Incidence rate per 1,000,000 5.7 33.8 27.6 6.5 1.1 0.4 0.2 Year Confirmed Cases 2015 1036 2016 283 2017 248 2018 445 2019 25

Rubella cases: Ukraine
20 40 Clinical Epi Lab Month of onset Number of cases SIA (6-9 Y) Cov: 67% SIA (1-9 Y) Cov: 57% National SIA Sub-national SIA 20 40 60 80 100 <1 year 1-4 years 5-9 years 10-14 years 15-19 years 20-29 years 30+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Ukraine age distribution, vaccination status, and incidence, to 5 10 15 25 Incidence rate per 1,000,000 18.7 16.2 23.8 7.1 4.5 0.3 4.1 Year Confirmed Cases 2015 2016 2017 2018 235 2019 17

Rubella cases: United Arab Emirates
5 Clinical Epi Lab Month of onset Number of cases 2 4 6 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases United Arab Emirates age distribution, vaccination status, and incidence, to 8 Incidence rate per 1,000,000 7.6 2.3 1.3 1.1 Year Confirmed Cases 2015 178 2016 135 2017 35 2018 12

Rubella cases: United Kingdom of Great Britain and Northern Ireland
1 2 Clinical Epi Lab Month of onset Number of cases 1 2 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases United Kingdom of Great Britain and Northern Ireland age distribution, vaccination status, and incidence, to 0.5 Incidence rate per 1,000,000 1.2 0.1 Year Confirmed Cases 2015 5 2016 2 2017 3 2018 2019

Rubella cases: United Republic of Tanzania
5 10 Clinical Epi Lab Month of onset Number of cases 5 10 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases United Republic of Tanzania age distribution, vaccination status, and incidence, to 2 4 Incidence rate per 1,000,000 4.5 0.7 0.6 0.3 Year Confirmed Cases 2015 31 2016 23 2017 28 2018 30

Rubella cases: NA 1 Month of onset Number of cases 1 2 3 Age at onset
1 Clinical Epi Lab Month of onset Number of cases SIA (6 M-15 Y) National SIA Sub-national SIA 1 2 3 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases NA age distribution, vaccination status, and incidence, to 4 Incidence rate per 1,000,000 3.4 Year Confirmed Cases 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019

Rubella cases: Viet Nam
10 20 Clinical Epi Lab Month of onset Number of cases 5 10 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Viet Nam age distribution, vaccination status, and incidence, to 1 2 3 Incidence rate per 1,000,000 2.6 0.8 0.6 0.3 0.4 0.2 Year Confirmed Cases 2014 193 2015 765 2016 301 2017 83 2018 40

Rubella cases: Yemen 80 60 Number of cases 40 20 Month of onset 150 60
20 40 60 80 Clinical Epi Lab Month of onset Number of cases 50 100 150 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Yemen age distribution, vaccination status, and incidence, to 20 40 60 Incidence rate per 1,000,000 59.1 48.2 29.3 9.2 3.5 0.9 0.7 Year Confirmed Cases 2015 159 2016 56 2017 41 2018 402

Rubella cases: Zambia 5 Month of onset Number of cases 1 2 3
5 Clinical Epi Lab Month of onset Number of cases 1 2 3 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Zambia age distribution, vaccination status, and incidence, to 0.5 1.5 Incidence rate per 1,000,000 1.6 0.9 0.8 0.3 Year Confirmed Cases 2015 91 2016 34 2017 14 2018 7 2019

Rubella cases: Zimbabwe
1 2 3 4 Clinical Epi Lab Month of onset Number of cases 1 2 <1 year 1-4 years 5-9 years 10-14 years 15-24 years 25-39 years 40+ years 0 doses 1 dose 2+ doses Unknown Age at onset Number of cases Zimbabwe age distribution, vaccination status, and incidence, to Incidence rate per 1,000,000 1.9 Year Confirmed Cases 2015 20 2016 2 2017 4 2018 1 2019

Disclaimer This document contains data provided to WHO by member states. Note that some member states only provide aggregate data to WHO, and for these,

Similar presentations

Presentation on theme: "Disclaimer This document contains data provided to WHO by member states. Note that some member states only provide aggregate data to WHO, and for these,"— Presentation transcript:

Similar presentations

About project

Feedback

Log in

Auth with social network:

Disclaimer This document contains data provided to WHO by member states. Note that some member states only provide aggregate data to WHO, and for these,

Similar presentations

Presentation on theme: "Disclaimer This document contains data provided to WHO by member states. Note that some member states only provide aggregate data to WHO, and for these,"— Presentation transcript:

Similar presentations

About project

Feedback